Pactiv Evergreen (PTVE) Q3 2024 earnings summary

Executive summary

• Q3 2024 net revenues were $1,333 million, down 3% year-over-year and flat sequentially, with adjusted EBITDA of $214 million and a 16% margin.

• Net loss of $213 million for Q3 2024, driven by a $322 million impairment charge from the sale of Pine Bluff and Waynesville facilities.

• Completed the sale of Pine Bluff and Waynesville mills on October 1, 2024, marking a strategic exit from mill operations and a shift to a capital-light model.

• Strategic initiatives focus on innovation, sustainability, operational efficiency, and portfolio repositioning for growth in 2025 and beyond.

• Emphasis on cost discipline, operational optimization, and progress on transformational strategy.

Financial highlights

• Q3 2024 net revenues: $1,333 million, down 3% year-over-year, mainly due to lower sales volume, partially offset by favorable pricing and product mix.

• Adjusted EBITDA was $214 million (16% margin), down 6% year-over-year but up 17% sequentially.

• Adjusted EPS was $0.36, up 13% year-over-year and 112% sequentially.

• Free cash flow for Q3 2024 was $190 million, a significant sequential and year-over-year increase.

• Net debt reduced to $3,327 million at quarter-end; net leverage at 4.3x, targeting 4x by year-end.

Outlook and guidance

• Updated full-year 2024 adjusted EBITDA guidance to $800–$810 million, reflecting the impact of divested operations and operational challenges.

• Capital expenditures for 2024 projected at $240–$250 million; free cash flow guidance at $180–$200 million.

• Net leverage expected to be around 4x by year-end 2024 and in the 3x range by end of 2025.

• Sufficient liquidity anticipated to support ongoing operations and growth investments.

• Excluding Pine Bluff, pro forma adjusted EBITDA for 2024 expected at $838–$848 million, with $15 million in incremental cost savings anticipated for 2025.